tiprankstipranks
Arjo AB Class B (DE:A39)
FRANKFURT:A39
Germany Market

Arjo AB (A39) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

A39 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Arjo
AB
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

A39 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:A39 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

A39 Financial Forecast

A39 Earnings Forecast

Next quarter’s earnings estimate for A39 is €0.04 with a range of €0.03 to €0.04. The previous quarter’s EPS was €0.04. A39 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year A39 has Outperformed its overall industry.
Next quarter’s earnings estimate for A39 is €0.04 with a range of €0.03 to €0.04. The previous quarter’s EPS was €0.04. A39 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.33% of the time in the same period. In the last calendar year A39 has Outperformed its overall industry.

A39 Sales Forecast

Next quarter’s sales forecast for A39 is €248.10M with a range of €243.01M to €251.06M. The previous quarter’s sales results were €249.52M. A39 beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year A39 has Outperformed its overall industry.
Next quarter’s sales forecast for A39 is €248.10M with a range of €243.01M to €251.06M. The previous quarter’s sales results were €249.52M. A39 beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 66.67% of the time in the same period. In the last calendar year A39 has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on DE:A39
TipRanks - xAI
TipRanks - xAI
€2.73€2.46
Hold
-0.90%
Downside
Downgraded
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on DE:A39
TipRanks - PerPlexity
TipRanks - PerPlexity
€2.64€2.55
Hold
2.77%
Upside
Downgraded
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on DE:A39
TipRanks - DeepSeek
TipRanks - DeepSeek
€2.46€2.55
Hold
2.77%
Upside
Reiterated
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:A39
TipRanks - Anthropic
TipRanks - Anthropic
€2.46€2.37
Hold
-4.57%
Downside
Reiterated
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:A39
TipRanks - Google
TipRanks - Google
€2.64€2.55
Hold
2.77%
Upside
Reiterated
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:A39
TipRanks - OpenAI
TipRanks - OpenAI
€2.64€2.55
Hold
2.77%
Upside
Reiterated
07/15/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on DE:A39
TipRanks - xAI
TipRanks - xAI
€2.73€2.46
Hold
-0.90%
Downside
Downgraded
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on DE:A39
TipRanks - PerPlexity
TipRanks - PerPlexity
€2.64€2.55
Hold
2.77%
Upside
Downgraded
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on DE:A39
TipRanks - DeepSeek
TipRanks - DeepSeek
€2.46€2.55
Hold
2.77%
Upside
Reiterated
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:A39
TipRanks - Anthropic
TipRanks - Anthropic
€2.46€2.37
Hold
-4.57%
Downside
Reiterated
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:A39
TipRanks - Google
TipRanks - Google
€2.64€2.55
Hold
2.77%
Upside
Reiterated
07/15/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:A39
TipRanks - OpenAI
TipRanks - OpenAI
€2.64€2.55
Hold
2.77%
Upside
Reiterated
07/15/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

A39 Analyst Recommendation Trends

Rating
Nov 25
Jan 26
Feb 26
Apr 26
Jul 26
Strong Buy
3
2
2
0
2
Buy
0
0
0
0
0
Hold
33
11
16
24
28
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
36
13
18
24
30
In the current month, A39 has received 2 Buy Ratings, 28 Hold Ratings, and 0 Sell Ratings. A39 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

A39 Stock Forecast FAQ

What is DE:A39’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:A39’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:A39, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Arjo AB Class B a Buy, Sell or Hold?
      Currently, no data Available
      What is Arjo AB Class B’s share price target?
      Currently, no data Available
      What do analysts say about Arjo AB Class B?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Arjo AB Class B?
      To buy shares of DE:A39, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.